Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: PREDICT

Oncodesign – preclinical evaluation of anticancer therapies

Posted on by

Oncodesign is a biotech company offering preclinical evaluation of anticancer therapies (Pharmimage, PREDICT, Chi-Mice, Nanocyclix, etc…).

Oncodesign – preclinical evaluation of anticancer therapies

Oncodesign Continue reading →

Posted in Biotech Companies, Biotech Companies France | Tagged anticancer therapies, anticancer therapy, biomarker, biomarker development, Chi-Mice, drug combination, drug formulation, eADMET, early ADMET, early ADMET model, early ADMET models, human kinome, imaging biomarker development, Jean-Marie Charpin, Kamel Boumali, kinase inhibitors, Nanocyclix, Nanokinib, Oncodesign, Oncodesign - preclinical evaluation of anticancer therapies, Oncodesign Biotech, Oncodesign Biotechnology, Pharm Image, pharmaco-imaging, pharmaco-imaging platform, PharmImage, Philippe Genne, PK profiling, preclinical anticancer drug evaluation, preclinical evaluation, preclinical evaluation anticancer therapies, preclinical evaluation anticancer therapy, preclinical evaluation of anticancer therapies, PREDICT, PREDICT platform, rat cancer model, rat cancer models, Scott Barksdale

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress